title: Re: Urinary Retention Rates after Intravesical OnabotulinumtoxinA Injection for Idiopathic Overactive Bladder in Clinical Practice and Predictors of this Outcome.
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Wein
mesh_terms: D065087:Acetylcholine Release Inhibitors / Q000009:adverse effects*; D019274:Botulinum Toxins, Type A / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D001743:Urinary Bladder / Q000187:drug effects*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D016055:Urinary Retention / Q000139:chemically induced*; D014563:Urodynamics / Q000187:drug effects*
chemical_list: D065087:Acetylcholine Release Inhibitors; D019274:Botulinum Toxins, Type A